Skip to main content

ULTRAVIST (Bayer Australia Ltd)

Product name
Date registered
Evaluation commenced
Decision date
Approval time
220 (255 working days)
Active ingredients
Registration type

ULTRAVIST is indicated for all angiographic and urographic examinations and for contrast enhancement in computerised tomography.,ULTRAVIST 300 or 370 is indicated for use in contrast-enhanced mammography (CEM) in adults, to visualise known or suspected lesions of the breast as an adjunct to mammography (with or without ultrasound).

Help us improve the Therapeutic Goods Administration site